R&D | November 23, 2025
Rafa Laboratories lands $186 million BARDA contract to develop life-saving trauma drug
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
The FDA’s review also revealed delays in Philips’ internal investigations, with 54 inquiries failing to meet targeted completion dates—23 of which were delayed by more than 100 days
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
FDA authorization was based on two years of clinical study data demonstrating that Essilor Stellest lenses significantly slowed myopia progression compared to single-vision control lenses
European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Phase III ARANOTE trial met primary endpoint, significantly increasing radiological progression-free survival (rPFS) with NUBEQA plus androgen deprivation therapy (ADT) compared to placebo plus ADT
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
_256_384.png){kind=logo}
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Subscribe To Our Newsletter & Stay Updated
